Business : AGC Biologics, Flen Health Partner On Wound Treatment Development
KUALA LUMPUR, Sept 24 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation (CDMO), has been selected by Belgian biopharmaceutical company Flen Health as its CDMO partner to provide process development, scale-up and Good Manufacturing Practice (GMP) manufacturing services for a new and improved wound and skin healing product.
We haven't written up this one. Bernama has the full story — the link below goes straight to it.
